Recurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report
2020 ◽
Vol 113
(11)
◽
pp. 454-456
◽
Keyword(s):
Tamoxifen exposure is a recognised risk for primary endometrial cancer. This case serves as a reminder to meticulously check the past medical history and inform patients of the risk-benefit of treatment as part of a shared-decision making process.
2019 ◽
Vol 37
(27_suppl)
◽
pp. 181-181
2018 ◽
Vol 6
(2)
◽
pp. 237
◽
Keyword(s):
2021 ◽
Vol 18
(4)
◽
pp. 2128
Keyword(s):
Keyword(s):